I-Mab Biopharma, the product of a CBC Group-engineered merger of two Chinese drug developers, has announced plans for a NASDAQ IPO.
CBC – formerly known as C-Bridge Capital – teamed up with traditional Chinese medicine producer Tasly Holding to invest $150 million in the merged entity in 2017. Combining Third Venture Biopharma...
Industry attempts to contextualize the advent of artificial intelligence as a key moment in the history of humanity risk overheating a market already on fire
SBI Cards and Payments, the State Bank of India's (SBI) credit card arm and a Carlyle Group portfolio company, is looking to raise INR60 billion ($840 million) through a domestic IPO.
Chinese healthcare-focused GP HighLight Capital has reached the first close of $300 million on its third US dollar-denominated fund, but further progress is likely to be delayed by the coronavirus outbreak.
Amber Group, a Hong Kong-based start-up offering crypto-based financial services, has raised $28 million in a Series A round led by Paradigm and Pantera Capital.